Behavioral problems of adolescents with chronic physical illness: A comparison of parent-report and self-report measures

M. Stawski,J. Auerbach,M. Barasch,Y. Lerner,R. Zimin,Mervin S. Miller

DOI: https://doi.org/10.1007/BF01987962

Abstract:

What problem does this paper attempt to address?

A novel variant of biallelic MME gene associated with autosomal recessive late-onset distal hereditary motor neuropathy in Chinese families

Bentuo Zhang,Qiang Gang,Lingchao Meng,Zhenyu Li,Xujun Chu,Haohao Wu,Junsu Yang,Baogang Huang,Kang Du

DOI: https://doi.org/10.1186/s12920-024-01996-3

2024-09-05

BMC Medical Genomics

Abstract:Distal hereditary motor neuropathies (dHMN) are a group of heterogeneous diseases and previous studies have reported that the compound heterozygous recessive MME variants cause dHMN. Our study found a novel homozygous MME variant and a reported compound heterozygous MME variant in two Chinese families, respectively. Next-generation sequencing and nerve conduction studies were performed for two probands. The probands in two families presented with the muscle weakness and wasting of both lower limbs and carried a c.2122 A > T (p.K708*) and c.1342 C > T&c.2071_2072delinsTT (p.R448*&p.A691L) variant, respectively. Prominently axonal impairment of motor nerves and slight involvement of sensory nerves were observed in nerve conduction study. Our study reported a "novel" nonsense mutation and a missense variant of autosomal recessive late-onset dHMN and reviewed reported MME variants associated with dHMN phenotype.

genetics & heredity
Genetic Spectrum of MCM3AP and Its Relationship with Phenotype of Charcot‐Marie‐Tooth Disease

Hai-Lin Dong,Qiao Wei,Jia-Qi Li,Hong-Fu Li,Ge Bai,Huan Ma,Zhi-Ying Wu

DOI: https://doi.org/10.1111/jns.12377

IF: 5.188

2020-01-01

Journal of the Peripheral Nervous System

Abstract:Mutations in MCM3AP have recently been reported to cause autosomal recessive Charcot-Marie-Tooth disease (CMT). However, only nine CMT families with MCM3AP mutations have been reported and genotype-phenotype correlation remains unclear. This study aimed to investigate the genetic spectrum of MCM3AP and its relationship with phenotype of CMT. Whole-exome sequencing (WES) was performed in the family and variants were validated by Sanger sequencing. Reverse transcription-PCR (RT-PCR) were performed in splicing analysis. We reported a novel splicing variant (c.5634-1G>T) and a known missense variant (c.2633G>A, p.Arg878His). Functional studies showed that c.5634-1G>T led to splicing defect and aberrant transcript eliminated by nonsense-mediated mRNA decay. The symptom of the patient was less severe and slowly progressed with axonal peripheral neuropathy compared to the reported CMT patients. Genotype-phenotype correlation analysis indicated that affected individuals with null mutations presented with delayed independent walking. The percentage of intellectual disability and loss of ambulation in the null group tended to be greater, although this failed to reach statistical significance. Our findings expand the genetic spectrum of MCM3AP and suggest that genotype-phenotype correlation would help genetic counseling of MCM3AP in CMT patients.
[A Genotyping Study of 13 Cases of Early-Onset Charcot-Marie-Tooth Disease].

Jia-Lu Xu,Yi Zhang,Cong-Ying Zhao,Pei-Fang Jiang,Zhe-Feng Yuan,Yong-Lin Yu,Zhe-Zhi Xia,Feng Gao

DOI: https://doi.org/10.7499/j.issn.1008-8830.2019.07.010

2019-01-01

Abstract:OBJECTIVE To study the clinical characteristics and genetic variation of early-onset Charcot-Marie-Tooth disease (CMT). METHODS Children with a clinical diagnosis of early-onset CMT were selected for the study. Relevant clinical data were collected, and electromyogram and CMT-related gene detection were performed and analyzed. RESULTS A total of 13 cases of early-onset CMT were enrolled, including 9 males (69%) and 4 females (31%). The mean age at consultation was 4.0±2.1 years. Among them, 12 children (92%) had an age of onset less than 2 years, 9 children (69%) were diagnosed with CMT type 1 (including 6 cases of Dejerine-Sottas syndrome), 1 child (8%) with intermediate form of CMT, and 3 children (23%) with CMT type 2. The genetic test results of these 13 children showed 6 cases (46%) of PMP22 duplication mutation, 3 cases (23%) of MPZ gene insertion mutation and point mutation, 3 cases (23%) of MFN2 gene point mutation, and 1 case (8%) of NEFL gene point mutation. Eleven cases (85%) carried known pathogenic mutations and 2 cases (15%) had novel mutations. The new variant c.394C>G (p.P132A) of the MPZ gene was rated as "possibly pathogenic" and the new variant c.326A>G (p.K109R) of the MFN2 gene was rated as "pathogenic". CONCLUSIONS Early-onset CMT is mainly caused by PMP22 gene duplication mutation and MPZ gene mutations. The clinical phenotype is mainly CMT type 1, among which Dejerine-Sottas syndrome accounts for a considerable proportion.
[Progress of Clinical and Genetic Research on Distal Hereditary Motor Neuropathy].

Lanxiao Cao,Guohua Zhao

DOI: https://doi.org/10.3760/cma.j.issn.1003-9406.2019.11.021

2019-01-01

Abstract:Distal hereditary motor neuropathy (dHMN) is a group of clinically and genetically heterogeneous disorders characterized by progressive distal weakness and atrophy. The onset of dHMN is at mid-adulthood or early childhood, and the symptoms are mainly present in the lower limbs. Besides weakness and atrophy of distal limb muscles, some patients may develop bulbar paralysis, and some may also present with mild sensory disturbance. Decreased or absent tendon reflexes may be discovered. Electromyography may show neurogenic damages. Muscular biopsy may reveal neurogenic amyotrophy. An increasing number of genes have been associated with dHMN. Pathogenesis of dHMN may include formation of protein aggregates, impairment of autophagy pathway, RNA processing, translation synthesis, axonal transport, endoplasmic reticulum stress, calcium channel and neuroprotection. A review for recent progress made on clinical characterization and molecular genetics of dHMN is provided.
Author Response for "genetic Spectrum and Clinical Profiles in a Southeast Chinese Cohort of Charcot‐Marie‐Tooth Disease"

Cong-Xin Chen,Hai-Lin Dong,Qiao Wei,Li-Xi Li,Hao Yu,Jia-Qi Li,Gong-Lu Liu,Hong-Fu Li,Ge Bai,Huan Ma,Zhi-Ying Wu

DOI: https://doi.org/10.1111/cge.13616

2019-01-01

Clinical Genetics

Abstract:Charcot-Marie-Tooth (CMT) disease is a heterogeneous group of inherited sensorimotor neuropathies. To clarify the genetic spectrum and clinical profiles in Chinese CMT patients, we enrolled 150 unrelated CMT patients from southeast China. We performed multiplex ligation-dependent probe amplification (MLPA) testing in all patients and next-generation sequencing (NGS) among those patients without PMP22 rearrangements. We identified PMP22 duplications in 40 patients and deletions in 12 patients. In addition, we found 19 novel variants and 36 known mutations in 57 patients. Among these 55 variants, 45 pathogenic or likely pathogenic variants were identified in 48 cases, and 10 variants with uncertain significance were identified in 9 cases. Therefore, we obtained a genetic diagnosis in 63.8% (88/138) of CMT patients and 66.7% (100/150) of all included patients. PMP22, GJB1, and MFN2 are the most common causative genes in CMT1 (demyelinated form), intermediate CMT, and CMT2 (axonal form), respectively. In this study, we identified a higher proportion of intermediate CMT, a relatively high frequency of NDRG1 mutations and clinical features of later onset age in CMT1A patients. Our results broaden the genetic and clinical spectrum of CMT patients, which can help optimize the genetic and clinical diagnosis.
[Studies on beta-lactam antibiotics for medicinal purpose. XII. Synthesis and structure-activity relationships of 7 beta-[alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-alpha-substituted acetamido]-7 alpha-metoxycephalosporanic acids].

S. Takano,I. Takakura,H. Ochiai,K. Momonoi,K. Tanaka,H. Shibata,M. Komatsu,T. Yasuda,M. Tai,Y. Fukuoka,I. Saikawa

DOI: https://doi.org/10.1248/YAKUSHI1947.102.7_617

1982-07-01

Abstract:
DNAJB2 C.184c>t Mutation Associated with Distal Hereditary Motor Neuropathy with Rimmed Vacuolar Myopathy

Meige Liu,Yan Xu,Daojun Hong,Lu Cong,Yangyi Fan,Jun Zhang

DOI: https://doi.org/10.5414/np301466

IF: 1.136

2022-01-01

Clinical Neuropathology

Abstract:Distal hereditary motor neuropathy (dHMN), also known as distal spinal muscular atrophy (dSMA), comprises a group of inherited peripheral neuropathies with great clinical and genetic heterogeneity, mainly characterized by progressive atrophy and weakness of distal muscle without clinical or electrophysiological sensory abnormalities. Next-generation sequencing is widely applied as an effective diagnostic technique to discover pathogenic genes in patients with dHMN. To date, at least 23 causal genes have been identified to be associated with dHMN, several of which encode chaperones. Here, we report a dHMN patient due to a homozygous c.184C>T variant in the DNAJB2 gene with rare neuropathic and myopathic characteristics on pathological examination. These findings might broaden the mutational spectrum of DNAJB2 and expand the tissue involvement of DNAJB2-related presentations.
Human factors, non-technical skills, professionalism and flight safety: their roles in improving patient outcome.

E. Armitage-Chan

DOI: https://doi.org/10.1111/vaa.12126

IF: 1.763

2014-05-01

Veterinary Anaesthesia and Analgesia

Abstract:
[Clinical, Pathological and Genetic Characteristics of 8 Patients with Distal Hereditary Motor Neuropathy].

M G Liu,P Fang,Y Wang,L Cong,Y,Y Yuan,Y Xu,J Zhang,D J Hong

DOI: https://doi.org/10.19723/j.issn.1671-167x.2021.05.025

2021-01-01

Abstract:OBJECTIVE:Distal hereditary motor neuropathy (dHMN) comprises a heterogeneous group of inherited disorders associated with neurodegeneration of motor nerves and neurons, mainly charac-terized by progressive atrophy and weakness of distal muscle without clinical or electrophysiological sensory abnormalities. To improve the recognition and diagnosis of the disease, we summarized the clinical manifestations, electrophysiological, pathological, and genetic characteristics in eight patients with dHMN.METHODS:Eight probands from different families diagnosed with dHMN were recruited in this study between June 2018 and April 2019 at Peking University People's Hospital. Eight patients underwent complete neurological examination and standard electrophysiological examinations. The clinical criteria were consistent with the patients presenting with a pure motor neuropathy with no sensory changes on electrophysiology. The detailed clinical symptoms, neurophysiological examinations, pathological features and gene mutations were analyzed retrospectively. Genetic testing was performed on the eight patients using targeted next-generation sequencing panel for inherited neuromuscular disorder and was combined with segregation analysis.RESULTS:The age of onset ranged between 11 and 64 years (median 39.5 years) in our dHMN patients. All the cases showed a slowly progressive disease course, mainly characterized by distal limb muscle weakness and atrophy. The motor nerve conduction revealed decreased compound muscle action potential amplitude and velocity, while the sensory nerve conduction velocities and action potentials were not affected. Needle electromyography indicated neurogenic chronic denervation in all patients. Muscle biopsy performed in two patients demonstrated neurogenic skeletal muscle damage. Sural nerve biopsy was performed in one patient, Semithin sections shows relatively normal density and structure of large myelinated fibers, except very few fibers with thin myelin sheaths, which suggested very mild sensory nerve involvement. Eight different genes known to be associated with dHMN were identified in the patients by next-generation sequencing, pathogenic dHMN mutations were identified in three genes, and the detection rate of confirmed genetic diagnosis of dHMN was 37.5% (3/8). Whereas five variants of uncertain significance (VUS) were identified, among which two novel variants co-segregated the phenotype.CONCLUSION:dHMN is a group of inherited peripheral neuropathies with great clinical and genetic heterogeneity. Next-generation sequencing is widely used to discover pathogenic genes in patients with dHMN, but more than half of the patients still remain genetically unknown.
Novelties of combustion synthesized titania ultrafiltration membrane in efficient removal of methylene blue dye from aqueous effluent.

Suresh M. Doke,G. Yadav

DOI: https://doi.org/10.1016/J.CHEMOSPHERE.2014.10.029

IF: 8.8

2014-12-01

Chemosphere

Abstract:
A deep intronic variant in MME causes autosomal recessive Charcot–Marie–Tooth neuropathy through aberrant splicing

Bianca R. Grosz,Jevin M. Parmar,Melina Ellis,Samantha Bryen,Cas Simons,Andre L. M. Reis,Igor Stevanovski,Ira W. Deveson,Garth Nicholson,Nigel Laing,Mathew Wallis,Gianina Ravenscroft,Kishore R. Kumar,Steve Vucic,Marina L. Kennerson

DOI: https://doi.org/10.1111/jns.12637

IF: 5.188

2024-06-13

Journal of the Peripheral Nervous System

Abstract:Background Loss‐of‐function variants in MME (membrane metalloendopeptidase) are a known cause of recessive Charcot–Marie–Tooth Neuropathy (CMT). A deep intronic variant, MME c.1188+428A>G (NM_000902.5), was identified through whole genome sequencing (WGS) of two Australian families with recessive inheritance of axonal CMT using the seqr platform. MME c.1188+428A>G was detected in a homozygous state in Family 1, and in a compound heterozygous state with a known pathogenic MME variant (c.467del; p.Pro156Leufs*14) in Family 2. Aims We aimed to determine the pathogenicity of the MME c.1188+428A>G variant through segregation and splicing analysis. Methods The splicing impact of the deep intronic MME variant c.1188+428A>G was assessed using an in vitro exon‐trapping assay. Results The exon‐trapping assay demonstrated that the MME c.1188+428A>G variant created a novel splice donor site resulting in the inclusion of an 83 bp pseudoexon between MME exons 12 and 13. The incorporation of the pseudoexon into MME transcript is predicted to lead to a coding frameshift and premature termination codon (PTC) in MME exon 14 (p.Ala397ProfsTer47). This PTC is likely to result in nonsense mediated decay (NMD) of MME transcript leading to a pathogenic loss‐of‐function. Interpretation To our knowledge, this is the first report of a pathogenic deep intronic MME variant causing CMT. This is of significance as deep intronic variants are missed using whole exome sequencing screening methods. Individuals with CMT should be reassessed for deep intronic variants, with splicing impacts being considered in relation to the potential pathogenicity of variants.

neurosciences,clinical neurology
Effect of Auditory Subliminal Stimulation on GSR

Hendrik F. Kotzé,A. T. Möller

DOI: https://doi.org/10.2466/pr0.1990.67.3.931

IF: 2.3

1990-12-01

Psychological Reports

Abstract:The present study was designed to investigate the possible effect of auditory subliminal stimulation on GSR. 38 undergraduate students were exposed subliminally to emotional words while GSR was monitored. The results confirmed the hypothesis that auditory subliminal stimulation would effect a significant increase in GSR.
One PMP22/MPZ and Three MFN2/GDAP1 Concomitant Variants Occurred in a Cohort of 189 Chinese Charcot-Marie-Tooth Families

Yongzhi Xie,Zhiqiang Lin,Xiaobo Li,Lei Liu,Shunxiang Huang,Huadong Zhao,Binghao Wang,Wanqian Cao,Zhengmao Hu,Jifeng Guo,Lu Shen,Beisha Tang,Ruxu Zhang

DOI: https://doi.org/10.3389/fneur.2021.736704

IF: 3.4

2022-01-28

Frontiers in Neurology

Abstract:Background and Aims Charcot-Marie-Tooth (CMT) disease is a clinically and genetically heterogeneous group of inherited peripheral neuropathies. The wide phenotypic variability may not be completely explained by a single mutation. Aims and Methods To explore the existence of concomitant variants in CMT, we enrolled 189 patients and performed molecular diagnosis by application of next-generation sequencing combined with multiplex ligation-dependent probe amplification. We conducted a retrospective analysis of patients harboring coinherited variants in different genes. Results Four families were confirmed to possess variants in two genes, accounting for 2.1% (4/189) of the total in our cohort. One CMT1 patient with PMP22 duplication and MPZ variant (c.286A>C, p.K96Q) exhibited moderate neuropathy with infantile onset, while her father possessing MPZ variant was mildly affected with adolescence onset. A CMT2 patient with heterozygous variants in MFN2 (c.613_622delGTCACCACAG, p.V205Sfs * 26) and GDAP1 (c.713G>T, p.W238L) exhibited childhood onset mild phenotype, while his mother with MFN2 variant developed bilateral pes cavus only. A CMT2 patient with heterozygous variants in MFN2 (c.839G>A, p.R280H) and GDAP1 (c.3G>T, p.M1?) presented infantile onset and rapid progression, while her father with MFN2 variant presented with absence of deep tendon reflexes. One sporadic CMT2 patient with early onset was confirmed harboring de novo MFN2 variant (c.1835C>T, p.S612F) and heterozygous GDAP1 variant (c.767A>G, p.H256R). Conclusion Our results suggest that the possibility of concomitant variants was not uncommon and should be considered when significant intrafamilial clinical heterogeneity is observed.

neurosciences,clinical neurology
A Novel Missense Mutation in Peripheral Myelin Protein-22 Causes Charcot-Marie-Tooth Disease

Li-Xi Li,Hai-Lin Dong,Bao-Guo Xiao,Zhi-Ying Wu

DOI: https://doi.org/10.4103/0366-6999.211539

IF: 6.133

2017-01-01

Chinese Medical Journal

Abstract:Background: Charcot-Marie-Tooth disease (CMT) is the most common inherited peripheral neuropathy. A great number of causative genes have been described in CMT, and among them, the heterozygous duplication of peripheral myelin protein-22 (PMP22) is the major cause. Although the missense mutation in PMP22 is rarely reported, it has been demonstrated to be associated with CMT. This study described a novel missense mutation of PMP22 in a Chinese family with CMT phenotype. Methods: Targeted next-generation sequencing (NGS) was used to screen the causative genes in a family featured with an autosomal dominant demyelinating form of CMT. The potential variants identified by targeted NGS were verified by Sanger sequencing and classified according to the American College of Medical Genetics and Genomics standards and guidelines. Further cell transfection studies were performed to characterize the function of the novel variant. Results: Using targeted NGS, a novel heterozygous missense variant in PMP22 (c.320G>A, p.G107D) was identified. In vitro cell functional studies revealed that mutant PMP22 protein carrying p.G107D mutation lost the ability to reach the plasma membrane, was mainly retained in the endoplasmic reticulum, and induced cell apoptosis. Conclusions: This study supported the notion that missense mutations in PMP22 give rise to a CMT phenotype, possibly through a toxic gain-of-function mechanism.
Mutations in MME cause an autosomal‐recessive Charcot–Marie–Tooth disease type 2

Yujiro Higuchi,Akihiro Hashiguchi,Junhui Yuan,Akiko Yoshimura,Jun Mitsui,Hiroyuki Ishiura,Masaki Tanaka,Satoshi Ishihara,Hajime Tanabe,Satoshi Nozuma,Yuji Okamoto,Eiji Matsuura,Ryuichi Ohkubo,Saeko Inamizu,Wataru Shiraishi,Ryo Yamasaki,Yasumasa Ohyagi,Jun‐ichi Kira,Yasushi Oya,Hayato Yabe,Noriko Nishikawa,Shinsuke Tobisawa,Nozomu Matsuda,Masayuki Masuda,Chiharu Kugimoto,Kazuhiro Fukushima,Satoshi Yano,Jun Yoshimura,Koichiro Doi,Masanori Nakagawa,Shinichi Morishita,Shoji Tsuji,Hiroshi Takashima

DOI: https://doi.org/10.1002/ana.24612

IF: 11.2

2016-03-17

Annals of Neurology

Abstract:OBJECTIVE: The objective of this study was to identify new causes of Charcot-Marie-Tooth (CMT) disease in patients with autosomal-recessive (AR) CMT.METHODS: To efficiently identify novel causative genes for AR-CMT, we analyzed 303 unrelated Japanese patients with CMT using whole-exome sequencing and extracted recessive variants/genes shared among multiple patients. We performed mutation screening of the newly identified membrane metalloendopeptidase (MME) gene in 354 additional patients with CMT. We clinically, genetically, pathologically, and radiologically examined 10 patients with the MME mutation.RESULTS: We identified recessive mutations in MME in 10 patients. The MME gene encodes neprilysin (NEP), which is well known to be one of the most prominent beta-amyloid (Aβ)-degrading enzymes. All patients had a similar phenotype consistent with late-onset axonal neuropathy. They showed muscle weakness, atrophy, and sensory disturbance in the lower extremities. All the MME mutations could be loss-of-function mutations, and we confirmed a lack/decrease of NEP protein expression in a peripheral nerve. No patients showed symptoms of dementia, and 1 patient showed no excess Aβ in Pittsburgh compound-B positron emission tomography imaging.INTERPRETATION: Our results indicate that loss-of-function MME mutations are the most frequent cause of adult-onset AR-CMT2 in Japan, and we propose that this new disease should be termed AR-CMT2T. A loss-of-function MME mutation did not cause early-onset Alzheimer's disease. Identifying the MME mutation responsible for AR-CMT could improve the rate of molecular diagnosis and the understanding of the molecular mechanisms of CMT.

neurosciences,clinical neurology
Clinical,pathological and Genetic Studies in a Chinese Charcot-Marie-Tooth Disease Type 2 Family

Wei Luo,Ye-Lei Tang,Bei-sha Tang,Mei-ping Ding,Guo-hua Zhao,Bao-rong Zhang,Kun Xia,Jian-guang Tang,Fu-feng Zhang,Ru-xu Zhang,Qi-dong Yang

DOI: https://doi.org/10.3785/j.issn.1008-9292.2005.06.011

2005-01-01

Abstract:OBJECTIVE:To report a Chinese Charcot-Marie-Tooth disease type 2 (CMT2) family.METHODS:All the members in the family were studied clinically,and 6 patients were studied electrophysiologically. Sural nerve biopsy was performed in the proband. PMP22 gene duplications were detected by highly polymorphic short tandem repeat. Point mutation analysis of PMP22, MPZ and NEFL gene was screened by PCR-SSCP combined with DNA direct sequencing. A genome-wide screening was carried out to the family.RESULT:Except 2 who had weakness and atrophy in both proximal and distal muscles of the lower limbs, all patients presented muscle wasting and a predominating weakness of distal parts of the lower limbs, and mild to moderate sensory impairments. In 6 patients who were subjected to elctrophysiological examinations, median-nerve conduction velocity (NCV) of the median nerve was normal. Electromyograms (EMGs) revealed signs of denervation with large motor unit potentials, fibrillation potentials and positive sharp waves. Sural nerve biopsy of the proband confirmed the presence of axonal neuropathy with an important loss of large myelinating fibers and a large number of clusters with mostly thinly myelinated axons. PMP22, MPZ and NEFL gene mutations were not found. The results of genome-wide screening revealed a linkage of CMT2 to a locus at chromosome 12q24.CONCLUSION:The results are consistent with the diagnosis of CMT2. This family represents a rare genetic type of CMT2 which can be designated as CMT2L.
Hereditary axonal neuropathy related to MME gene mutation in a family with fetomaternal alloimmune glomerulonephritis

M. Dupuis,J. M. Raymackers,N. Ackermans,S. Boulanger,C. Verellen-Dumoulin

DOI: https://doi.org/10.1007/s13760-020-01275-9

2020-01-23

Acta Neurologica Belgica

Abstract:We report a consanguineous family with a homozygous and heterozygous membrane metallo-endopeptidase (MME) mutation (c.467delC) and two clinical conditions: fetomaternal alloimmune membranous glomerulopathy (FMG) and hereditary motor and sensory axonal neuropathy. The penetrance of both phenotypes was variable. Some individuals experienced unusually fast neurological degradation. Pain and vasomotor signs were frequent complaints, possibly due to a loss of the neutral endopeptidase (NEP, the MME gene product) function and its subsequent inability to degrade substance P and vasomotor peptides. Electrophysiological and nerve biopsy findings were consistent with predominantly axonal neuropathy. This specific clinical phenotype was attributed to a c.467delC MME gene mutation. Diagnosis of such a mutation is important but can be challenging, due to allele dropout. Heterozygous subjects who had already reached the expected age of disease onset had peripheral neuropathy, but also suffered from additional diseases. Neurologists should advise women of childbearing age with MME mutations to seek pre-pregnancy genetic advice and nephrologists should search for neuropathy in patients with FMG.

neurosciences,clinical neurology
A polymorphic AT-repeat causes frequent allele dropout for an MME mutational hotspot exon

Helle Høyer,Hilde T Hilmarsen,Raute Sunder-Plassmann,Geir J Braathen,Peter M Andersen,Christian Beetz,Sandra Hacker,Øystein L Holla,Ingo Kurth,Wolfgang N Löscher,Simone B C F Reiter,Sabine Rudnik-Schöneborn,Linda Strand,Reinhard Windhager,Martina Witsch-Baumgartner,Jan Senderek,Michaela Auer-Grumbach

DOI: https://doi.org/10.1136/jmedgenet-2021-108281

2022-03-22

Journal of Medical Genetics

Abstract:Pathogenic variants in the MME gene cause dominant and recessive late-onset axonal hereditary neuropathy, that is, axonal Charcot-Marie-Tooth syndrome (LOCMT2). Here, we report next-generation sequencing (NGS) and Sanger sequencing (SS) results of 28 LOCMT2 patients carrying either the repeatedly reported c.467del p.(Pro156Leufs*14) or the c.440–2A>C variants. We demonstrate that an intronic AT-repeat in close proximity to these two mutations is frequently causing an allele dropout during SS that result in false genotyping in a considerable proportion of patients. This may result in an incorrect diagnosis, which has a considerable clinical impact for genetic counselling and prognosis.Recent studies have demonstrated that both heterozygous and biallelic variants in MME (encoding the metalloprotease neprilysin) are a frequent cause of LOCMT2 (MIM: 617017).1–3 The heterozygotes variants cause a milder phenotype with reduced penetrance. Besides the large spectrum of rare or even single pathogenic MME variants, the frameshift deletion c.467del p.(Pro156Leufs*14) and the splice site mutation c.440–2A>C have been recurrently reported in patients with autosomal dominant and autosomal recessive LOCMT2.2–4 Although PCR is considered to be a robust technology and a reliable tool to be used for routine diagnosis, allele-specific sequence variations occasionally may provoke amplification failure of one of the two alleles at a given locus.5 Such an allele dropout has also been shown for the c.467del mutation in MME in one consanguineous family.4 In this study, registries at the Medical University of Vienna and Telemark Hospital Trust were searched for LOCMT2 individuals carrying the MME variants NM\_007289.3:c.467del p.(Pro156Leufs*14) and NM\_007289.3:c.440–2A>C. We ascertained 28 individuals from 16 families (MH1-MH16) afflicted with LOCMT2. For segregation analysis three healthy family members were also included. The families originated from Austria, Germany, Norway and Sweden.Whole exome sequencing, NGS-based multigene panel sequencing or SS of the MME gene was performed and analysed as …

genetics & heredity
The distal hereditary motor neuropathies

Alexander M Rossor,Bernadett Kalmar,Linda Greensmith,Mary M Reilly

DOI: https://doi.org/10.1136/jnnp-2011-300952

2011-10-25

Abstract:The distal hereditary motor neuropathies (dHMN) comprise a heterogeneous group of diseases that share the common feature of a length-dependent predominantly motor neuropathy. Many forms of dHMN have minor sensory abnormalities and/or a significant upper-motor-neuron component, and there is often an overlap with the axonal forms of Charcot-Marie-Tooth disease (CMT2) and with juvenile forms of amyotrophic lateral sclerosis and hereditary spastic paraplegia. Eleven causative genes and four loci have been identified with autosomal dominant, recessive and X-linked patterns of inheritance. Despite advances in the identification of novel gene mutations, 80% of patients with dHMN have a mutation in an as-yet undiscovered gene. The causative genes have implicated proteins with diverse functions such as protein misfolding (HSPB1, HSPB8, BSCL2), RNA metabolism (IGHMBP2, SETX, GARS), axonal transport (HSPB1, DYNC1H1, DCTN1) and cation-channel dysfunction (ATP7A and TRPV4) in motor-nerve disease. This review will summarise the clinical features of the different subtypes of dHMN to help focus genetic testing for the practising clinician. It will also review the neuroscience that underpins our current understanding of how these mutations lead to a motor-specific neuropathy and highlight potential therapeutic strategies. An understanding of the functional consequences of gene mutations will become increasingly important with the advent of next-generation sequencing and the need to determine the pathogenicity of large amounts of individual genetic data.

surgery,psychiatry,clinical neurology
[Genetic distribution in Chinese patients with hereditary peripheral neuropathy]

X X Liu,X H Duan,S Zhang,A P Sun,Y S Zhang,D S Fan

DOI: https://doi.org/10.19723/j.issn.1671-167X.2022.05.015

2022-10-18

Abstract:Objective: To analyze the distribution characteristics of hereditary peripheral neuropathy (HPN) pathogenic genes in Chinese Han population, and to explore the potential pathogenesis and treatment prospects of HPN and related diseases. Methods: Six hundred and fifty-six index patients with HPN were enrolled in Peking University Third Hospital and China-Japan Friendship Hospital from January 2007 to May 2022. The PMP22 duplication and deletion mutations were screened and validated by multiplex ligation probe amplification technique. The next-generation sequencing gene panel or whole exome sequencing was used, and the suspected genes were validated by Sanger sequencing. Results: Charcot-Marie-Tooth (CMT) accounted for 74.3% (495/666) of the patients with HPN, of whom 69.1% (342/495) were genetically confirmed. The most common genes of CMT were PMP22 duplication, MFN2 and GJB1 mutations, which accounted for 71.3% (244/342) of the patients with genetically confirmed CMT. Hereditary motor neuropathy (HMN) accounted for 16.1% (107/666) of HPN, and 43% (46/107) of HPN was genetically confirmed. The most common genes of HMN were HSPB1, aminoacyl tRNA synthetases and SORD mutations, which accounted for 56.5% (26/46) of the patients with genetically confirmed HMN. Most genes associated with HMN could cause different phenotypes. HMN and CMT shared many genes (e.g. HSPB1, GARS, IGHMBP2). Some genes associated with dHMN-plus shared genes associated with amyotrophic lateral sclerosis (KIF5A, FIG4, DCTN1, SETX, VRK1), hereditary spastic paraplegia (KIF5A, ZFYVE26, BSCL2) and spinal muscular atrophy (MORC2, IGHMBP, DNAJB2), suggesting that HMN was a continuum rather than a distinct entity. Hereditary sensor and autosomal neuropathy (HSAN) accounted for a small proportion of 2.6% (17/666) in HPN. The most common pathogenic gene was SPTLC1 mutation. TTR was the main gene causing hereditary amyloid peripheral neuropathy. The most common types of gene mutations were p.A117S and p.V50M. The symptoms were characterized by late-onset and prominent autonomic nerve involvement. Conclusion: CMT and HMN are the most common diseases of HPN. There is a large overlap between HMN and motor-CMT2 pathogenic genes, and some HMN pathogenic genes overlap with amyotrophic lateral sclerosis, hereditary spastic hemiplegia and spinal muscular atrophy, suggesting that there may be a potential common pathogenic pathway between different diseases.

Behavioral problems of adolescents with chronic physical illness: A comparison of parent-report and self-report measures

A novel variant of biallelic MME gene associated with autosomal recessive late-onset distal hereditary motor neuropathy in Chinese families

Genetic Spectrum of MCM3AP and Its Relationship with Phenotype of Charcot‐Marie‐Tooth Disease

[A Genotyping Study of 13 Cases of Early-Onset Charcot-Marie-Tooth Disease].

[Progress of Clinical and Genetic Research on Distal Hereditary Motor Neuropathy].

Author Response for "genetic Spectrum and Clinical Profiles in a Southeast Chinese Cohort of Charcot‐Marie‐Tooth Disease"

[Studies on beta-lactam antibiotics for medicinal purpose. XII. Synthesis and structure-activity relationships of 7 beta-[alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-alpha-substituted acetamido]-7 alpha-metoxycephalosporanic acids].

DNAJB2 C.184c>t Mutation Associated with Distal Hereditary Motor Neuropathy with Rimmed Vacuolar Myopathy

Human factors, non-technical skills, professionalism and flight safety: their roles in improving patient outcome.

[Clinical, Pathological and Genetic Characteristics of 8 Patients with Distal Hereditary Motor Neuropathy].

Novelties of combustion synthesized titania ultrafiltration membrane in efficient removal of methylene blue dye from aqueous effluent.

A deep intronic variant in MME causes autosomal recessive Charcot–Marie–Tooth neuropathy through aberrant splicing

Effect of Auditory Subliminal Stimulation on GSR

One PMP22/MPZ and Three MFN2/GDAP1 Concomitant Variants Occurred in a Cohort of 189 Chinese Charcot-Marie-Tooth Families

A Novel Missense Mutation in Peripheral Myelin Protein-22 Causes Charcot-Marie-Tooth Disease

Mutations in MME cause an autosomal‐recessive Charcot–Marie–Tooth disease type 2

Clinical,pathological and Genetic Studies in a Chinese Charcot-Marie-Tooth Disease Type 2 Family

Hereditary axonal neuropathy related to MME gene mutation in a family with fetomaternal alloimmune glomerulonephritis

A polymorphic AT-repeat causes frequent allele dropout for an MME mutational hotspot exon

The distal hereditary motor neuropathies

[Genetic distribution in Chinese patients with hereditary peripheral neuropathy]